Stryker Company Leadership
SYK Stock | USD 388.14 1.57 0.40% |
Stryker's insiders are aggressively selling. The analysis of insiders' sentiment of trading Stryker stock suggests that most insiders are panicking at this time. Stryker employs about 52 K people. The company is managed by 36 executives with a total tenure of roughly 170 years, averaging almost 4.0 years of service per executive, having 1444.44 employees per reported executive.
Kevin Lobo Chairman Chairman of the Board, President, Chief Executive Officer |
William Berry President Principal Accounting Officer, Vice President, Corporate Controller |
Stryker's Insider Buying Vs Selling
0
Selling | Buying |
Latest Trades
2024-11-07 | Kevin Lobo | Disposed 57313 @ 368.7 | View | ||
2024-09-17 | M Kathryn Fink | Disposed 7347 @ 366.98 | View | ||
2024-09-13 | M Kathryn Fink | Disposed 2121 @ 370 | View | ||
2024-08-27 | Viju Menon | Disposed 600 @ 355 | View | ||
2024-08-06 | Ronda E Stryker | Disposed 190000 @ 323.46 | View | ||
2024-08-02 | Glenn S Boehnlein | Disposed 20000 @ 333 | View | ||
2024-03-07 | William E Berry Jr | Disposed 7690 @ 358.48 | View | ||
2024-02-05 | Ronda E Stryker | Disposed 201146 @ 342.9 | View | ||
2024-02-02 | Allan C Golston | Disposed 3273 @ 341 | View | ||
2023-11-28 | William E Berry Jr | Disposed 573 @ 292.28 | View |
Monitoring Stryker's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Stryker |
Stryker's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Stryker's future performance. Based on our forecasts, it is anticipated that Stryker will maintain a workforce of about 52000 employees by December 2024.Stryker's latest congressional trading
Congressional trading in companies like Stryker, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Stryker by those in governmental positions are based on the same information available to the general public.
2024-11-11 | Representative Ro Khanna | Acquired Under $15K | Verify | ||
2024-10-08 | Representative Ro Khanna | Acquired Under $15K | Verify | ||
2023-01-25 | Representative Michael C Burgess | Acquired $100K to $250K | Verify | ||
2022-11-29 | Representative Michael C Burgess | Acquired Under $15K | Verify | ||
2022-11-15 | Representative Michael C Burgess | Acquired Under $15K | Verify | ||
2022-09-20 | Representative Michael C Burgess | Acquired Under $15K | Verify | ||
2022-06-03 | Representative Michael C Burgess | Acquired Under $15K | Verify | ||
2022-04-29 | Representative Michael C Burgess | Acquired Under $15K | Verify | ||
2022-04-15 | Representative Michael C Burgess | Acquired Under $15K | Verify | ||
2022-03-23 | Representative Michael C Burgess | Acquired Under $15K | Verify | ||
2021-11-17 | Representative Michael C Burgess | Acquired Under $15K | Verify |
Stryker Management Team Effectiveness
The company has Return on Asset of 0.0711 % which means that on every $100 spent on assets, it made $0.0711 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1887 %, implying that it generated $0.1887 on every 100 dollars invested. Stryker's management efficiency ratios could be used to measure how well Stryker manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Stryker's Return On Capital Employed is quite stable compared to the past year. Return On Assets is expected to rise to 0.11 this year, although the value of Return On Tangible Assets will most likely fall to 0.10. At this time, Stryker's Total Current Liabilities is quite stable compared to the past year. Liabilities And Stockholders Equity is expected to rise to about 41.9 B this year, although the value of Non Current Liabilities Other will most likely fall to about 1.8 B.Common Stock Shares Outstanding is expected to rise to about 426.3 M this year. Net Income Applicable To Common Shares is expected to rise to about 2.8 B this year
Stryker Workforce Comparison
Stryker is rated third in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 394,900. Stryker retains roughly 52,000 in number of employees claiming about 13% of equities under Health Care industry.
Stryker Profit Margins
The company has Net Profit Margin of 0.16 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.22 %, which entails that for every 100 dollars of revenue, it generated $0.22 of operating income.Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Gross Profit Margin | 0.5 | 0.6389 |
|
| |||||
Net Profit Margin | 0.096 | 0.1544 |
|
| |||||
Operating Profit Margin | 0.14 | 0.1897 |
|
| |||||
Pretax Profit Margin | 0.13 | 0.1792 |
|
| |||||
Return On Assets | 0.11 | 0.0793 |
|
| |||||
Return On Equity | 0.19 | 0.1702 |
|
|
Stryker Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Stryker insiders, such as employees or executives, is commonly permitted as long as it does not rely on Stryker's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Stryker insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
---|---|---|---|---|---|
2024-12-01 | 0.1429 | 3 | 21 | 166,370 | 561,264 |
2024-09-01 | 0.1379 | 4 | 29 | 34,235 | 284,847 |
2024-06-01 | 1.2857 | 9 | 7 | 5,877 | 13,529 |
2024-03-01 | 0.7292 | 35 | 48 | 356,070 | 1,465,094 |
2023-12-01 | 0.2692 | 7 | 26 | 198,416 | 385,449 |
2023-09-01 | 0.2 | 1 | 5 | 2,000 | 8,739 |
2023-06-01 | 1.0 | 14 | 14 | 10,550 | 225,022 |
2023-03-01 | 0.5455 | 36 | 66 | 345,350 | 1,250,084 |
2022-12-01 | 0.3158 | 6 | 19 | 199,369 | 395,988 |
2022-09-01 | 0.25 | 1 | 4 | 2,343 | 2,244 |
2022-06-01 | 0.8421 | 16 | 19 | 28,902 | 765,950 |
2022-03-01 | 1.25 | 25 | 20 | 417,297 | 97,723 |
2021-12-01 | 0.2045 | 9 | 44 | 19,897 | 353,176 |
2021-09-01 | 0.2857 | 2 | 7 | 5,659 | 725,526 |
2021-06-01 | 1.2105 | 23 | 19 | 145,604 | 255,379 |
2021-03-01 | 1.2 | 18 | 15 | 339,679 | 139,015 |
2020-12-01 | 0.3077 | 4 | 13 | 128,520 | 228,124 |
2020-09-01 | 0.5 | 4 | 8 | 32,567 | 200,987 |
2020-06-01 | 0.4857 | 17 | 35 | 41,562 | 89,036 |
2020-03-01 | 0.9286 | 26 | 28 | 458,663 | 779,602 |
2019-12-01 | 0.625 | 5 | 8 | 13,706 | 44,984 |
2019-09-01 | 0.4828 | 14 | 29 | 71,723 | 349,233 |
2019-06-01 | 1.0 | 20 | 20 | 36,305 | 63,969 |
2019-03-01 | 0.8 | 36 | 45 | 607,254 | 324,744 |
2018-12-01 | 0.3684 | 7 | 19 | 47,042 | 84,753 |
2018-09-01 | 1.2 | 6 | 5 | 49,487 | 76,332 |
2018-06-01 | 0.7647 | 13 | 17 | 12,908 | 75,419 |
2018-03-01 | 0.8103 | 47 | 58 | 699,630 | 348,088 |
2017-12-01 | 0.2727 | 3 | 11 | 46,551 | 114,139 |
2017-09-01 | 0.625 | 5 | 8 | 8,172 | 31,826 |
2017-06-01 | 0.5 | 18 | 36 | 393,330 | 720,492 |
2017-03-01 | 1.16 | 58 | 50 | 685,925 | 157,362 |
2016-12-01 | 0.0704 | 5 | 71 | 32,684 | 451,961 |
2016-09-01 | 0.0429 | 3 | 70 | 6,720 | 417,482 |
2016-06-01 | 0.098 | 10 | 102 | 133,995 | 770,179 |
2016-03-01 | 0.4472 | 55 | 123 | 748,537 | 741,629 |
2015-12-01 | 0.08 | 6 | 75 | 101,481 | 556,137 |
2015-09-01 | 0.0145 | 1 | 69 | 5,000 | 410,974 |
2015-06-01 | 0.2273 | 5 | 22 | 31,043 | 1,142,550 |
2015-03-01 | 1.26 | 63 | 50 | 634,149 | 600,207 |
2014-12-01 | 0.0682 | 3 | 44 | 32,151 | 327,200 |
2014-09-01 | 0.0385 | 1 | 26 | 12,000 | 185,000 |
2014-06-01 | 0.0313 | 1 | 32 | 8,618 | 203,142 |
2014-03-01 | 0.8182 | 45 | 55 | 496,980 | 275,763 |
2013-12-01 | 0.0323 | 2 | 62 | 48,950 | 491,978 |
2013-09-01 | 0.0513 | 2 | 39 | 24,000 | 281,853 |
2013-06-01 | 0.1143 | 4 | 35 | 143,956 | 326,134 |
2013-03-01 | 1.0286 | 36 | 35 | 486,613 | 160,018 |
2012-12-01 | 0.0714 | 2 | 28 | 13,801 | 244,000 |
2012-06-01 | 0.0313 | 1 | 32 | 10,000 | 289,000 |
2012-03-01 | 1.1379 | 33 | 29 | 303,981 | 215,132 |
2011-06-01 | 0.1585 | 13 | 82 | 443,418 | 1,575,037 |
2011-03-01 | 0.6222 | 28 | 45 | 518,512 | 452,560 |
2010-12-01 | 0.1667 | 1 | 6 | 2,000 | 340,000 |
2010-03-01 | 0.8333 | 25 | 30 | 739,758 | 898,375 |
2009-09-01 | 0.16 | 4 | 25 | 17,330 | 2,010,500 |
2009-06-01 | 0.5 | 4 | 8 | 21,750 | 280,000 |
2009-03-01 | 7.5 | 15 | 2 | 606,875 | 40,000 |
2008-09-01 | 0.2381 | 5 | 21 | 107,000 | 609,151 |
2008-03-01 | 0.2564 | 10 | 39 | 302,850 | 1,254,326 |
2007-12-01 | 0.1538 | 6 | 39 | 196,000 | 1,235,115 |
2007-09-01 | 0.0256 | 1 | 39 | 1,000.00 | 750,000 |
2005-12-01 | 1.0 | 1 | 1 | 5,000 | 525.00 |
2005-06-01 | 0.7273 | 8 | 11 | 367,000 | 940,000 |
2004-09-01 | 0.5 | 1 | 2 | 2,500 | 265,555 |
2004-03-01 | 0.9 | 9 | 10 | 133,600 | 232,893 |
2003-12-01 | 0.65 | 13 | 20 | 466,000 | 727,034 |
2003-09-01 | 0.25 | 2 | 8 | 93,034 | 425,034 |
Stryker Notable Stakeholders
A Stryker stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Stryker often face trade-offs trying to please all of them. Stryker's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Stryker's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Kevin Lobo | Chairman of the Board, President, Chief Executive Officer | Profile | |
Donald Payerle | President Replacement | Profile | |
Bradford Saar | President Medical | Profile | |
William Berry | Principal Accounting Officer, Vice President, Corporate Controller | Profile | |
Yin Becker | Vice President - Communications, Public Affairs and Corporate Marketing | Profile | |
Timothy Scannell | Group President of Medsurg and Neurotechnology | Profile | |
Robert Fletcher | Vice President Chief Legal Officer | Profile | |
Brian White | President Solutions | Profile | |
Dylan Crotty | President Instruments | Profile | |
Brent Ladd | President Endoscopy | Profile | |
Glenn Boehnlein | Chief Financial Officer, Vice President | Profile | |
Viju Menon | Group President - Global Quality and Business Operations | Profile | |
Maurice BenMayor | President Pacific | Profile | |
Glenn CPA | VP CFO | Profile | |
Andrew Silvernail | Independent Director | Profile | |
Sherilyn McCoy | Independent Director | Profile | |
Ronda Stryker | Independent Director | Profile | |
Allan Golston | Lead Independent Director | Profile | |
Giovanni Caforio | Independent Director | Profile | |
Roch Doliveux | Independent Director | Profile | |
Rajeev Suri | Independent Director | Profile | |
Mary Brainerd | Independent Director | Profile | |
Srikant Datar | Independent Director | Profile | |
Dana McMahon | VP Officer | Profile | |
Lisa Tatum | Independent Director | Profile | |
Robert Cohen | CTO Replacement | Profile | |
Preston Wells | Vice President - Investor Relations | Profile | |
Spencer Stiles | Group President Orthopaedics and Spine | Profile | |
Andrew Pierce | Group Neurotechnology | Profile | |
Dragana Bunjevac | Middle Europe | Profile | |
Stuart Silk | Middle Europe | Profile | |
Jason Beach | Vice Relations | Profile | |
M Fink | Chief Human Resource Officer, Vice President | Profile | |
Mike Panos | North RD | Profile | |
Alan Douville | Chief VP | Profile | |
J Pierce | Group President MedSurg and Neurotechnology | Profile |
About Stryker Management Performance
The success or failure of an entity such as Stryker often depends on how effective the management is. Stryker management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Stryker management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Stryker management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | 0.16 | 0.10 | |
Return On Capital Employed | 0.12 | 0.21 | |
Return On Assets | 0.08 | 0.11 | |
Return On Equity | 0.17 | 0.19 |
Stryker Workforce Analysis
Traditionally, organizations such as Stryker use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Stryker within its industry.Stryker Manpower Efficiency
Return on Stryker Manpower
Revenue Per Employee | 394.2K | |
Revenue Per Executive | 569.4M | |
Net Income Per Employee | 60.9K | |
Net Income Per Executive | 87.9M | |
Working Capital Per Employee | 88.4K | |
Working Capital Per Executive | 127.7M |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Stryker. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. For more information on how to buy Stryker Stock please use our How to buy in Stryker Stock guide.You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stryker. If investors know Stryker will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Stryker listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.2 | Dividend Share 3.2 | Earnings Share 9.31 | Revenue Per Share 57.728 | Quarterly Revenue Growth 0.119 |
The market value of Stryker is measured differently than its book value, which is the value of Stryker that is recorded on the company's balance sheet. Investors also form their own opinion of Stryker's value that differs from its market value or its book value, called intrinsic value, which is Stryker's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Stryker's market value can be influenced by many factors that don't directly affect Stryker's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Stryker's value and its price as these two are different measures arrived at by different means. Investors typically determine if Stryker is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Stryker's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.